Key takeaways Semaglutide, liraglutide, dulaglutide, and tirzepatide are GLP-1 medications that mimic hormones to control blood sugar and reduce weight
10.1111/NEP.13979 Summary Keywords safety, SGLT2 (sodium-glucose cotransporter 2) inhibitor, adverse drug (event), evidence medicine, review Citation Mascolo A, Di Napoli R, Balzano N, Cappetta D, Urbanek K, De Angelis A, Scisciola L, Di Meo I, Sullo MG, Rafaniello C and Sportiello L (2022) Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
After 8 weeks of tumor induction, mice were randomized into experimental groups
D., Zheng, Y., Wang, J
Semaglutide helps control appetite, but lifestyle changes are still necessary for long-term success in losing weight and keeping it off
Under federal regulations, drugs can be compounded if they are in shortage or to personalize a medication for a specific patient, such as making a drug thats normally a liquid into pill form